These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 29160808)
1. Interplay between Colistin Resistance, Virulence and Fitness in Acinetobacter baumannii. Da Silva GJ; Domingues S Antibiotics (Basel); 2017 Nov; 6(4):. PubMed ID: 29160808 [No Abstract] [Full Text] [Related]
2. Outer Membranes of Polymyxin-Resistant Jiang X; Yang K; Han ML; Yuan B; Li J; Gong B; Velkov T; Schreiber F; Wang L; Li J ACS Infect Dis; 2020 Oct; 6(10):2698-2708. PubMed ID: 32871077 [TBL] [Abstract][Full Text] [Related]
3. The Effect of Colistin Resistance-Associated Mutations on the Fitness of Mu X; Wang N; Li X; Shi K; Zhou Z; Yu Y; Hua X Front Microbiol; 2016; 7():1715. PubMed ID: 27847502 [No Abstract] [Full Text] [Related]
4. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii. Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177 [TBL] [Abstract][Full Text] [Related]
5. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation. Bahador A; Farshadzadeh Z; Raoofian R; Mokhtaran M; Pourakbari B; Pourhajibagher M; Hashemi FB Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):24. PubMed ID: 29859115 [TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii. García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Resistance Mechanisms and Virulence of Colistin- and Carbapenem-Resistant Ilsan NA; Lee YJ; Kuo SC; Lee IH; Huang TW Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34198665 [No Abstract] [Full Text] [Related]
8. A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii. Boll JM; Crofts AA; Peters K; Cattoir V; Vollmer W; Davies BW; Trent MS Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6228-E6237. PubMed ID: 27681618 [TBL] [Abstract][Full Text] [Related]
9. Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii. Pelletier MR; Casella LG; Jones JW; Adams MD; Zurawski DV; Hazlett KR; Doi Y; Ernst RK Antimicrob Agents Chemother; 2013 Oct; 57(10):4831-40. PubMed ID: 23877686 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Polymyxin Resistance. Moffatt JH; Harper M; Boyce JD Adv Exp Med Biol; 2019; 1145():55-71. PubMed ID: 31364071 [TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide-Deficient Kamoshida G; Akaji T; Takemoto N; Suzuki Y; Sato Y; Kai D; Hibino T; Yamaguchi D; Kikuchi-Ueda T; Nishida S; Unno Y; Tansho-Nagakawa S; Ubagai T; Miyoshi-Akiyama T; Oda M; Ono Y Front Microbiol; 2020; 11():573. PubMed ID: 32373082 [No Abstract] [Full Text] [Related]
12. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates. Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C mBio; 2019 Jul; 10(4):. PubMed ID: 31311879 [TBL] [Abstract][Full Text] [Related]
13. Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance. Wand ME; Bock LJ; Bonney LC; Sutton JM J Antimicrob Chemother; 2015 Aug; 70(8):2209-16. PubMed ID: 25904728 [TBL] [Abstract][Full Text] [Related]
14. Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii. Durante-Mangoni E; Del Franco M; Andini R; Bernardo M; Giannouli M; Zarrilli R Diagn Microbiol Infect Dis; 2015 Jul; 82(3):222-6. PubMed ID: 25858028 [TBL] [Abstract][Full Text] [Related]
15. PmrAB, the two-component system of Yamada N; Kamoshida G; Shiraishi T; Yamaguchi D; Matsuoka M; Yamauchi R; Kanda N; Kamioka R; Takemoto N; Morita Y; Fujimuro M; Yokota S-i; Yahiro K J Bacteriol; 2024 May; 206(5):e0043523. PubMed ID: 38661375 [TBL] [Abstract][Full Text] [Related]
16. A Prospective Study of Leung LM; McElheny CL; Gardner FM; Chandler CE; Bowler SL; Mettus RT; Spychala CN; Fowler EL; Opene BNA; Myers RA; Goodlett DR; Doi Y; Ernst RK J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30567747 [No Abstract] [Full Text] [Related]
17. Loss of LPS is involved in the virulence and resistance to colistin of colistin-resistant Acinetobacter nosocomialis mutants selected in vitro. Vila-Farrés X; Ferrer-Navarro M; Callarisa AE; Martí S; Espinal P; Gupta S; Rolain JM; Giralt E; Vila J J Antimicrob Chemother; 2015 Nov; 70(11):2981-6. PubMed ID: 26311838 [TBL] [Abstract][Full Text] [Related]
18. Reinforcing Lipid A Acylation on the Cell Surface of Acinetobacter baumannii Promotes Cationic Antimicrobial Peptide Resistance and Desiccation Survival. Boll JM; Tucker AT; Klein DR; Beltran AM; Brodbelt JS; Davies BW; Trent MS mBio; 2015 May; 6(3):e00478-15. PubMed ID: 25991684 [TBL] [Abstract][Full Text] [Related]
19. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii. Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568 [TBL] [Abstract][Full Text] [Related]
20. Growth Rate and Biofilm Formation Ability of Clinical and Laboratory-Evolved Colistin-Resistant Strains of Farshadzadeh Z; Taheri B; Rahimi S; Shoja S; Pourhajibagher M; Haghighi MA; Bahador A Front Microbiol; 2018; 9():153. PubMed ID: 29483899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]